1. Home
  2. CCCC vs NRDY Comparison

CCCC vs NRDY Comparison

Compare CCCC & NRDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCCC
  • NRDY
  • Stock Information
  • Founded
  • CCCC 2015
  • NRDY 2007
  • Country
  • CCCC United States
  • NRDY United States
  • Employees
  • CCCC N/A
  • NRDY N/A
  • Industry
  • CCCC Biotechnology: Pharmaceutical Preparations
  • NRDY Computer Software: Prepackaged Software
  • Sector
  • CCCC Health Care
  • NRDY Technology
  • Exchange
  • CCCC Nasdaq
  • NRDY Nasdaq
  • Market Cap
  • CCCC 160.1M
  • NRDY 155.4M
  • IPO Year
  • CCCC 2020
  • NRDY N/A
  • Fundamental
  • Price
  • CCCC $2.46
  • NRDY $1.17
  • Analyst Decision
  • CCCC Strong Buy
  • NRDY Hold
  • Analyst Count
  • CCCC 4
  • NRDY 7
  • Target Price
  • CCCC $8.50
  • NRDY $1.60
  • AVG Volume (30 Days)
  • CCCC 2.9M
  • NRDY 552.6K
  • Earning Date
  • CCCC 11-03-2025
  • NRDY 11-06-2025
  • Dividend Yield
  • CCCC N/A
  • NRDY N/A
  • EPS Growth
  • CCCC N/A
  • NRDY N/A
  • EPS
  • CCCC N/A
  • NRDY N/A
  • Revenue
  • CCCC $34,240,000.00
  • NRDY $178,378,000.00
  • Revenue This Year
  • CCCC N/A
  • NRDY $3.34
  • Revenue Next Year
  • CCCC N/A
  • NRDY $10.69
  • P/E Ratio
  • CCCC N/A
  • NRDY N/A
  • Revenue Growth
  • CCCC 16.55
  • NRDY N/A
  • 52 Week Low
  • CCCC $1.09
  • NRDY $0.75
  • 52 Week High
  • CCCC $6.52
  • NRDY $2.18
  • Technical
  • Relative Strength Index (RSI)
  • CCCC 51.01
  • NRDY 41.87
  • Support Level
  • CCCC $2.31
  • NRDY $1.06
  • Resistance Level
  • CCCC $2.82
  • NRDY $1.21
  • Average True Range (ATR)
  • CCCC 0.22
  • NRDY 0.08
  • MACD
  • CCCC 0.03
  • NRDY -0.00
  • Stochastic Oscillator
  • CCCC 52.41
  • NRDY 44.90

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

About NRDY Nerdy Inc.

Nerdy Inc is a curated direct-to-consumer platform for live online learning. Its proprietary platform leverages technology, including artificial intelligence ("AI"), to connect students, users, parents, guardians, and purchasers of all ages to tutors, instructors, subject matter experts, educators, and other professionals. The company provides learning experiences across numerous subjects and multiple formats, including one-on-one instruction, small group tutoring, large format classes, tutor chat, essay review, adaptive assessments, and self-study tools. The company generates revenue by selling services to learners and institutions for one-on-one instruction and small group tutoring.

Share on Social Networks: